Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027604 |
---|---|
Receipt number | R000031635 |
Scientific Title | A clinical study for cardioprotective effect of empagliflozin in T2DM patients with heart failure and exploring associated factors |
Date of disclosure of the study information | 2017/06/02 |
Last modified on | 2023/12/07 16:54:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/06/02 14:55:57 | ||
2 | Update | 2017/07/26 17:53:59 | Name of secondary funder(s) Name of secondary funder(s) |
|
3 | Update | 2017/09/12 16:58:51 | Acronym Acronym |
|
4 | Update | 2017/12/04 11:39:25 | Recruitment status Anticipated trial start date |
|
5 | Update | 2018/06/13 16:48:44 | Anticipated trial start date |
|
6 | Update | 2019/06/04 19:16:13 | Date of IRB Last follow-up date |
|
7 | Update | 2019/06/04 19:22:47 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/12/12 18:54:26 | Key inclusion criteria Key inclusion criteria |
|
9 | Update | 2021/06/04 14:18:40 | Key inclusion criteria Key inclusion criteria |
|
10 | Update | 2021/12/07 16:01:47 | Last follow-up date |
|
11 | Update | 2022/06/21 15:33:20 | Last follow-up date |
|
12 | Update | 2023/06/07 14:29:35 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Address |
|
13 | Update | 2023/06/07 14:30:37 | Last follow-up date |
|
14 | Update | 2023/12/07 16:54:47 | Recruitment status |